Search

Zigang Dong

from Overland Park, KS
Age ~62
Get Report
Also known as:
Dong Zigang, Doug Zigang
Related to:
Christopher DongWei Y Ma, 60Kevin Dong, 32Wei-Ya Ma, 60
Connected to:
Aaron P Dong, 34Alfred Y Dong, 41Amy N Dong, 53Austin N Dong, 31Bill Y Dong, 63Bruce Y Dong, 93Carolyn Dong, 33Charlie T Dong, 65Chenchen Dong, 41Christopher D Dong, 49

Zigang Dong Phones & Addresses

  • Overland Park, KS
  • 1208 19Th St SW, Austin, MN 55912 (507) 287-6374
  • 1400 18Th St, Austin, MN 55912 (507) 433-8372
  • 3406 Tralee Ln, Rochester, MN 55906 (507) 287-6374
  • 160 Willowdale Dr, Frederick, MD 21702
  • 1400 18Th St SW, Austin, MN 55912 (507) 358-7734

Work

Position: Precision Production Occupations

Education

Degree: Bachelor's degree or higher

Emails

z***[email protected]

Publications

Us Patents

Bioactive Compounds And Methods Of Uses Thereof

View page
US Patent:
7351739, Apr 1, 2008
Filed:
Apr 29, 2005
Appl. No.:
11/118915
Inventors:
Chi-Tang Ho - East Brunswick NJ, US
Naisheng Bai - Highland Park NJ, US
Zigang Dong - Rochester MN, US
Ann M. Bode - Cannon Falls MN, US
Slavik Dushenkov - Fort Lee NJ, US
Assignee:
Wellgen, Inc. - New Brunswick NJ
The Regents of the University of Minnesota - Minneapolis MN
Rutgers, the State University of New Jersey - New Brunswick NJ
International Classification:
A01N 43/20
A01N 43/24
A61K 31/335
C07D 303/00
C07D 305/14
US Classification:
514475, 549332
Abstract:
In one aspect, the present invention provides compounds having formula I or IV as shown below:.

Cancer Treatment Method And Compositions

View page
US Patent:
20040156799, Aug 12, 2004
Filed:
Dec 5, 2003
Appl. No.:
10/479899
Inventors:
Zigang Dong - Austin MN, US
Ann Bode - Cannon Falls MN, US
Wei-Ya Ma - Austin MN, US
International Classification:
A61K007/42
A61K031/12
A61K031/22
US Classification:
424/059000, 514/546000, 514/678000
Abstract:
The present invention provides pharmaceutical compositions including: a combination of a compound of the formula (I) wherein Ris C-Calkyl and Ris independently —H or —OH, or a pharmaceutically acceptable salt thereof; and a phorbol compound. The present invention also provides for these and other compositions and their use for the treatment of established cancers or tumors.

Selective Inhibitors Of C-Jun N-Terminal Kinase

View page
US Patent:
20110269810, Nov 3, 2011
Filed:
Apr 4, 2011
Appl. No.:
13/079254
Inventors:
Yuan-Ping Pang - Rochester MN, US
Anuradha Vummenthala - Iowa City IA, US
Jewn Giew Park - Rochester MN, US
Shao-Hua Wang - Rochester MN, US
Zigang Dong - Rochester MN, US
Ann M. Bode - Cannon Falls MN, US
Yong Yeon Cho - Rochester MN, US
Assignee:
Regents of the University of Minnesota - Saint Paul MN
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 31/403
A61P 19/02
A61P 3/10
A61P 25/28
C07D 209/56
C12N 9/99
US Classification:
514410, 548420, 435184
Abstract:
Compositions and methods for treating, preventing, or ameliorating one or more symptoms, disorders, or conditions associated with particular c-Jun N-terminal kinase(s) (JNKs) activity are provided. Compositions contain small molecules such as pyrazoloanthrones.

Dominant Negative Deletion Mutants Of C-Jun And Their Use In The Prevention And Treatment Of Cancer

View page
US Patent:
6699842, Mar 2, 2004
Filed:
Mar 10, 1994
Appl. No.:
08/213433
Inventors:
Nancy H. Colburn - Middletown MD
Zigang Dong - Frederick MD
Powel H. Brown - North Potomac MD
Michael J. Birrer - Potomac MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A01N 4304
US Classification:
514 44, 424 932
Abstract:
The inhibition of AP-1 activity by dominant negative deletion mutants of c-jun is disclosed. This inhibition of AP-1 activity is shown to be associated with inhibition of tumor promoter-induced neoplastic transformation. Therefore, the invention relates to the utilization of dominant negative deletion mutants of c-jun which are inhibitory to tumor promotor-induced neoplastic transformation as therapeutic agents in the prevention and treatment of cancer in mammals.

Skin Care Formulations And Skin Cancer Treatment

View page
US Patent:
20200179404, Jun 11, 2020
Filed:
Jun 8, 2018
Appl. No.:
16/620382
Inventors:
- Minneapolis MN, US
Zigang Dong - Austin MN, US
Assignee:
Regents of the University of Minnesota - Minneapolis MN
International Classification:
A61K 31/573
A61P 35/04
A61K 31/58
A61K 9/00
Abstract:
An example technique for treating a skin cancer condition includes administering a therapeutically effective amount of a p53-related protein kinase (PRPK) inhibitor to a patient having skin cancer or having a high risk of developing skin cancer. An example composition includes a therapeutically effective amount of a PRPK inhibitor for treating a skin cancer condition. An example composition includes a pharmaceutically effective amount of at least one anti-solar ultraviolet (anti-sUV) combination for preventing a skin cancer condition. The at least one anti-sUV combination is chosen from the combinations: avobenzone and octinoxate; octocrylene and zinc oxide; avobenzone, octocrylene, and titanium dioxide; or avobenzone, octocrylene, and zinc oxide.

Inhibitors Of Beta-Catenin In Treatment Of Colorectal Cancer

View page
US Patent:
20150374662, Dec 31, 2015
Filed:
Jun 30, 2015
Appl. No.:
14/788373
Inventors:
Ann Marie Bode - Cannon Falls MN, US
Zigang Dong - Austin MN, US
Srinivasa Reddy Kanamata Reddy - Austin MN, US
International Classification:
A61K 31/404
A61K 31/4545
A61K 31/4184
A61K 31/454
C07D 209/34
C07D 209/38
Abstract:
Compounds are disclosed which are effective for inhibiting β-catenin or disrupting a β-catenin/Tcf-4 complex, and for causing effective attenuation of colon carcinogenesis. The compounds may be effective treatment for colorectal cancer (CRC) when administered in an effective dose to a patient afflicted therewith.

Isbn (Books And Publications)

Dietary Modulation of Cell Signaling Pathways

View page
Author

Zigang Dong

ISBN #

0849381487

Control profile
Zigang Dong from Overland Park, KS, age ~62 Get Report